SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4,744.36 |
| Enterprise Value ($M) | 4,399.50 |
| Book Value ($M) | 946.38 |
| Book Value / Share | 32.85 |
| Price / Book | 5.01 |
| NCAV ($M) | 632.59 |
| NCAV / Share | 21.96 |
| Price / NCAV | 7.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.09 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.11 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.02 |
| Current Ratio | 7.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 742.04 |
| Assets | 1,055.84 |
| Liabilities | 109.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 290.51 |
| Operating Income | 103.19 |
| Net Income | 89.16 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 123.42 |
| Cash from Investing | -163.44 |
| Cash from Financing | 27.01 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 4.40 | -11.97 | |
| 13G/A | Redmile Group, LLC | 2.80 | -53.25 | |
| 13G/A | Fmr Llc | 14.94 | 28.17 | |
| 13G/A | Vanguard Group Inc | 10.05 | 17.79 | |
| 13G/A | BlackRock, Inc. | 13.80 | 118.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 32,418 | 140,040 | 23.15 | |
| 66,444 | 257,030 | 25.85 | |
| 34,828 | 137,712 | 25.29 | |
| 48,936 | 163,538 | 29.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KPTI – Karyopharm Therapeutics Inc. |
| KRON – Kronos Bio, Inc. | KURA – Kura Oncology, Inc. |
| KYTX – Kyverna Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io